NIOX VERO FeNO Testing Starter Kit – Asthma Airway Inflammation Testing

The NIOX VERO is the leading point-of-care FeNO (Fractional Exhaled Nitric Oxide) testing device used worldwide, with over 45 million tests performed globally. It provides a fast, non-invasive measurement of airway inflammation in a single breath, helping clinicians diagnose asthma, guide inhaled corticosteroid therapy and monitor treatment adherence. This starter kit includes the device and everything you need to begin testing immediately.

Key Features

• Results in Seconds: Delivers a precise FeNO measurement in a single 10-second or 6-second exhalation, with no warm-up time required.
• Two Exhalation Modes: Standard 10-second mode for adults and a 6-second mode suitable for children from age 4 and patients with reduced lung function.
• Flow Rate Control: Patented technology guides patients to maintain a steady exhalation throughout the test, virtually eliminating failed attempts and ensuring accurate, repeatable results.
• Interactive On-Screen Animations: Three engaging animations with sound effects coach patients through the breathing manoeuvre, making testing straightforward even for first-time users.
• Patient ID Tracking: Built-in patient identification feature lets you store and recall individual patient records, making it easy to monitor FeNO trends over time.
• Breathing Handle: Ergonomic handle design makes the exhalation process intuitive and comfortable for patients of all ages.
• Clinically Validated: Fully compliant with ATS/ERS guidelines for FeNO measurement. Recognised in NICE, BTS/SIGN and GINA asthma management guidelines.
• Compact and Portable: Lightweight handheld device that fits easily into any consultation room or can travel between clinic locations.

Clinical Applications

• Asthma Diagnosis: Elevated FeNO supports a diagnosis of eosinophilic airway inflammation, helping distinguish asthma from other causes of cough and breathlessness.
• Treatment Optimisation: Monitor response to inhaled corticosteroids and adjust dosing objectively rather than relying on symptoms alone.
• Adherence Monitoring: A rising FeNO level in a previously controlled patient can indicate poor adherence to preventer inhalers.
• Exacerbation Prevention: Regular FeNO monitoring has been shown to reduce exacerbation risk in susceptible patients compared to standard symptom-based monitoring.

What Is Included

• NIOX VERO device
• NIOX Breathing Handle
• Test kit of NIOX Sensors (disposable mouthpieces with integrated NO filter)
• Power supply and charging dock
• Quick start guide and user manual

Applications

GP surgeries, respiratory clinics, allergy clinics, paediatric departments, occupational health units and any setting where objective airway inflammation testing supports clinical decision-making. Contact our team for information on bulk pricing, sensor refill packs and ongoing supply.